Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_assertion type Assertion NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_head.
- NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_assertion description "[Primary hyperoxaluria type II (PH2) is a rare monogenic disorder that is characterized by a lack of the enzyme that catalyzes the reduction of hydroxypyruvate to D-glycerate, the reduction of glyoxylate to glycolate and the oxidation of D-glycerate to hydroxypyruvate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_provenance.
- NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_assertion evidence source_evidence_literature NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_provenance.
- NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_assertion SIO_000772 10484776 NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_provenance.
- NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_assertion wasDerivedFrom befree-2016 NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_provenance.
- NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_assertion wasGeneratedBy ECO_0000203 NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_provenance.